Leucomycin A1

• UNSPSC Description:

  Leucomycin A1 is a main component of the leucomycin complex produced by Streptomyces kitasatoensis, Leucomycin A1 is an antibiotic[1].

• Target Antigen:

  Antibiotic; Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/leucomycin-a1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O[C@H]([C@H]([C@H](O[C@@]1([H])C[C@@](O)([C@@H](OC(CC(C)C)=O)[C@H](C)O1)C)[C@@H](C)O2)N(C)C)[C@]2([H])O[C@H]3[C@H](C[C@H]([C@H](/C=C/C=C/C[C@@H](C)OC(C[C@@H](O)[C@@H]3OC)=O)O)C)CC=O

• Molecular Weight:

  785.96

• References & Citations:

  [1]Watanabe T, et al. Studies on leucomycin. V. Isolation of mycaros-4-isovalerate from leucomycin A1. Bulletin of the Chemical Society of Japan, 1961, 34(9): 1285-1288.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  16846-34-7